This website is intended for healthcare professionals only

Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

This issue of touchREVIEWS in Oncology & Haematology brings together a diverse collection of articles reflecting the growing complexity of cancer care and the continued evolution of precision medicine across tumour types. From rare malignancies and treatment-related challenges to emerging targeted therapies and novel biological insights, the contributions highlight both recent progress and the significant […]

Policy

An Introduction to Policy

Supported by:
IN COLLABORATION WITH
Mark CompleteCompleted
BookmarkBookmarked

In this Future Leaders interview, Dr Gyawali discusses how patient-centered care, evidence-based practice and mentorship have shaped his career, and why curiosity, resilience and purpose are essential for the next generation of oncologists.

Mark CompleteCompleted
BookmarkBookmarked

In this Future Leaders interview, Dr Soniya Dulal discusses the global mentors who shaped her career, the importance of building sustainable oncology systems in Nepal and how precision medicine, palliative care and international collaboration can improve patient outcomes in resource-limited settings.

Mark CompleteCompleted
BookmarkBookmarked

February has already been very busy across regulation, clinical research and community awareness - and we're only half way through! See below a round-up of the main breakthroughs and what to look out for during the rest of the month. ...

3d illustration of human body liver
Mark CompleteCompleted
BookmarkBookmarked

The newly released Lancet Commission on hepatocellular carcinoma (HCC) is a powerful wake-up call to the global health community. It highlights that more than 60% of liver cancer cases are preventable through action on hepatitis, metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol use. Without intervention, HCC cases could double by 2050 – reaching over 1.5 million new cases annually and 1.37 million deaths.

Mark CompleteCompleted
BookmarkBookmarked

In this interview, Prof Mark Lawler discusses the Europe’s Beating Cancer Plan key achievements, challenges and future directions.

Mark CompleteCompleted
BookmarkBookmarked

World Cancer Day is a campaign run by the Union for International Cancer Control (UICC). It is observed annually on February 4th, and unites the world in the fight against cancer. The theme for 2025–27, "United by Unique", highlights the individual ...

women in cancer
Mark CompleteCompleted
BookmarkBookmarked

In this interview, we are joined by President-Elect of the European Cancer Organisation (ECO), Dr Isabel Teresa Rubio (Head of Breast Surgical Oncology at Clínica Universidad de Navarra, Professor of Surgery at the University of Navarra, Spain). She discusses ...

Mark CompleteCompleted
BookmarkBookmarked

7 January 2025, Brussels - The European Cancer Organisation (ECO) is pleased to announce the appointment of Elisabetta Zanon as its new Chief Executive Officer, effective 3 February. Elisabetta is a senior professional with more than 20 years of experience in European affairs, much ...

Developed by Touch

The PrEvCan – Cancer Prevention Across Europe – campaign, initiated by the European Oncology Nursing Society (EONS) and supported by ESMO, aims to reduce the burden of cancer by promoting a different way we can decrease cancer risk each month. This August, ...

Developed by Touch
Coverage from: AACR Highlights

The purpose of phase I clinical trials are to evaluate the safety, dosage and potential side effects of a new drug or treatment in humans for the first time. In this touchONCOLOGY interview, we speak with Dr Vivek Subbiah (University ...

Developed by Touch
Coverage from: AACR Highlights

Precision medicine aims to tailor medical treatments to individual patients based on their characteristics and genetic makeup. Phase I clinical trials are seeing changes in their objectives and designs in the era of precision medicine. In this touchONCOLOGY interview, we ...

Developed by Touch

This July, the PrEvCan campaign is dedicated to raising awareness about women's cancer risk in connection with breastfeeding and hormone replacement therapy (HRT).  Initiated by the European Oncology Nursing Society (EONS), and with ESMO as a key campaign partner, the ...

Developed by Touch

The relationship between breastfeeding and a reduction in cancer risk is the focus of the PrEvCan Campaign, this July.  Initiated by the European Oncology Nursing Society (EONS), and with ESMO as a key campaign partner, the PrEvCan – Cancer Prevention Across ...

The European Code Against Cancer (ECAC) recommends that if you drink alcohol of any type you should limit your intake and that not drinking alcohol is best for cancer prevention. This March, the PrEvCan campaign, spearheaded by EONS to promote ...

Developed by Touch
Coverage from: ESSO Highlights

The European Society of Surgical Oncology (ESSO), along with other cancer-related European societies, supported the proposal for cross-multidisciplinary training in oncology at the EU level. It was a pleasure to talk with Prof. Pompiliu Piso (Hospital Barmherzige Brueder, Regensburg, Germany) ...

Developed by Touch
Coverage from: ESSO Highlights

The European Society of Surgical Oncology (ESSO) recently released an open letter urging the European Commission to recognise surgical oncology as a specialist discipline in the EU, entitled 'Time to act: Maximizing the benefits of surgical oncology for cancer patients ...

Rare diseases can present numerous challenges for those living with these conditions and the healthcare professionals caring for them. In this interview we discuss some of these with Lisa Sarfaty, VP of Communication and Engagement for NORD (The National Organization ...

Our society partner, NORD (The National Organization for Rare Disorder) has planned several initiatives to support this year’s Rare Disease Day on 28 February.  These activities are aimed at raising awareness about rare diseases and the challenges faced by people ...

Load More...
Close Popup